• AbioMed: Morgan Stanley upgrades to equal-weight from underweight. PT up 0.6% to $380.
  • Advanced Energy: Benchmark Company lowers PT to $90 from $110. Maintains buy rating.
  • Bio-Techne: Benchmark Company lowers target to $480 from $540. Maintains buy rating.
  • Blucora: Benchmark Company raises PT to $32 from $26. Maintains buy rating.
  • Boohoo: Liberum downgrades from hold to sell targeting GBp 35.
  • British American Tobacco: Goldman Sachs downgrades to neutral from buy, targeting GBp 3800.
  • Cirrus Logic: Needham & Co raised its target to $85 from $73. Maintains buy rating.
  • Cleveland-Cliffs: Wolfe Research downgrades to underperform from peerperform. PT down 10% to $12.
  • Ecolab: Deutsche Bank downgrades to hold from buy. PT down 5.6% to $135.
  • Essentra: Jefferies remains Buy with a price target cut from GBp 340 to GBp 300.
  • IPG Photonics: Benchmark Company lowers PT to $130 from $165. Maintains buy rating.
  • Microsoft: Macquarie reinstated coverage with a recommendation of neutral. PT up 2.6% to $234.
  • NXP Semi: Jefferies lifts PT to $185 from $165. Maintains buy rating.
  • Ocado: J.P. Morgan downgrades from neutral to underweight, targeting GBp 500.
  • Premier: Baird raised the recommendation to outperform from neutral. PT up 29% to $41.
  • Snowflake: Macquarie initiated coverage with a recommendation of neutral. PT set to $173.
  • The Clorox Co: D.A. Davidson & Co raise PT to $155 from $124. Maintains neutral rating.
  • Unilever: Jefferies remains Buy with a price target reduced from GBp 4600 to 4500.
  • Universal Logistics: Stifel downgrades to hold from buy. PT up 4.2% to $36.